gabac

Gaboxadol (hydrochloride) is a GABAA receptor agonist.

Gabaculine is an irreversible inhibitor of GABA transaminase (GABA-T; Ki: 2.9 μM). Gabaculine alters plastid development and differentially affects the abundance of plastid-encoded DPOR and nuclear-encoded GluTR.

GABAA agonist

GABAA-ρ antagonist

(R)-3-Amino-4-hydroxybutanoic acid (L-beta-Homoserine), a serine derivative, is a full agonist at the human recombinant rho1 GABAC receptor and a modulator of GABAA and GABAB receptors.

Muscimol hydrochloride is the salt form of Muscimol, the main psychoactive component of Amanita muscaria, a potent and selective GABAA receptor agonist and partial GABAC receptor agonist, with no activity on GABAB receptors. It is commonly used in central neuroscience research, with analgesic, anxiolytic and neuroprotective effects, with the advantage of being able to cross the blood-brain barrier and can be taken orally.

(R)-4-Amino-3-hydroxybutyric acid, also known as (R)-GABOB, acts as a modulator of GABA receptors, specifically binding to both GABAA and GABAB receptors and blocking GABA reuptake in rat brain synaptosomes. Additionally, it serves as a GABAC receptor agonist, triggering currents in patch-clamp assays with Xenopus oocytes that express the human receptor. In vivo studies reveal its capability to suppress electrical discharges in the amygdala in cats undergoing N-amidinobenzamide-triggered seizures, indicating its potential therapeutic application in managing seizure disorders.

Guanidinoacetic acid (Standard) is methylated in the liver to creatine and is involved in the regulation of energy metabolism that can be used as a standard for quantitative assays to study the creatine synthesis pathway, inherited metabolic disorders (e.g., guanidinoacetic acid methyltransferase deficiency), neurological disorders, and as a nutritional supplement to enhance athletic performance.Guanidinoacetic acid is a regulator of AMP-activated protein kinase (AMPK), can act as an inhibitor to down-regulate miR - 133a expression, and is an antagonist of the GABAC receptor.

Very high affinity ClC-2 blocker (apparent KD ~ 50 pM). Slows ClC-2 activation and inhibits slow-gating but does not inhibit open ClC-2 channels. Selective for ClC-2 over other ClC family members (ClC-0, ClC-1, ClC-3 and ClC-4), CFTR, GABAC, CaCC and KV1.